Repositorio Dspace

Stabilization of the PP2A-B56? complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML

Mostrar el registro sencillo del ítem

dc.contributor.author Romero-Murillo, Silvia
dc.contributor.author Peris, Irene
dc.contributor.author Luciano, Anna-María
dc.contributor.author Marcotegui, Nerea
dc.contributor.author Vicente, Carmen
dc.contributor.author Tran, Brian
dc.contributor.author Barrie, Kelsey
dc.contributor.author O'Connor, Caitlin-M
dc.contributor.author Torres-López, Andrea
dc.contributor.author Mateos, María-C
dc.contributor.author Cayuela-Fuentes, María-Luisa
dc.contributor.author Mulero, Victoriano
dc.contributor.author Fernández-Irigoyen, Joaquin
dc.contributor.author Santamaria, Enrique
dc.contributor.author Odero, María-D
dc.contributor.author Narla, Goutham
dc.date.accessioned 2026-11-11T09:07:13Z
dc.date.available 2026-11-11T09:07:13Z
dc.date.issued 2026-10-22
dc.identifier.citation Romero-Murillo S, Peris I, Lucianò AM, Marcotegui N, Vicente C, Tran B, et al. Stabilization of the PP2A-B56? complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML. JCI Insight. 22 de octubre de 2026;11(20):e205218. doi:10.1172/jci.insight.205218
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29194
dc.description.abstract Cell metabolic rewiring is associated with resistance to venetoclax-azacitidine (Ven-Aza) combination therapy and relapse in patients with acute myeloid leukemia (AML). Drug-resistant cells exhibit an enhanced reliance on oxidative phosphorylation (OXPHOS) for energy production. Therefore, impairing mitochondrial metabolism represents an exciting strategy to face this unmet clinical need. We recently demonstrated that the specific activation of the phosphatase PP2A-B56? enhances the proapoptotic efficacy of venetoclax in AML. Here, through leveraging unbiased multi-omics-based approaches and using both genetic and pharmacological tools, we define key roles for the tumor suppressor PP2A-B56? complex in OXPHOS regulation and treatment response in disease-relevant AML models. From a translational perspective, the specific stabilization of PP2A-B56? heterocomplex with the potentially novel PP2A molecular glue activator, RPT04402, reduces OXPHOS levels in treatment-resistant AML cells and improves treatment response in both Ven-Aza-sensitive and -resistant AML cell lines, primary cells, and in vivo models. Together, our work supports further research on targeted combination therapy approaches based on PP2A-B56? stabilization to counteract OXPHOS-related treatment resistance and improve AML responses in a patient population with historically poor outcomes.
dc.language.iso eng
dc.publisher AMER SOC CLINICAL INVESTIGATION INC
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Bridged Bicyclo Compounds, Heterocyclic/pharmacology/therapeutic use
dc.subject.mesh Humans
dc.subject.mesh Leukemia, Myeloid, Acute/drug therapy/metabolism/pathology/genetics
dc.subject.mesh Sulfonamides/pharmacology/therapeutic use
dc.subject.mesh Drug Resistance, Neoplasm/drug effects
dc.subject.mesh Protein Phosphatase 2/metabolism/genetics
dc.subject.mesh Animals
dc.subject.mesh Oxidative Phosphorylation/drug effects
dc.subject.mesh Mice
dc.subject.mesh Azacitidine/pharmacology/therapeutic use
dc.subject.mesh Cell Line, Tumor
dc.subject.mesh Xenograft Model Antitumor Assays
dc.subject.mesh Antineoplastic Combined Chemotherapy Protocols/pharmacology
dc.subject.mesh Mitochondria/metabolism/drug effects
dc.subject.mesh Female
dc.title Stabilization of the PP2A-B56? complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42742967
dc.relation.publisherversion https://insight.jci.org/articles/view/205218
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1172/jci.insight.205218
dc.journal.title JCI Insight
dc.identifier.essn 2379-3708


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta